Answers are grounded in this paper and cite their sources.
Health systems tend to judge procurement on unit price and delivery compliance, yet shortages of medicines and supplies do harm patients. This integrative review asks whether sustainable procurement strengthens healthcare supply chain resilience and, through resilience, improves service outcomes. It starts from a foundation base of 25 sources and adds a targeted screen of recent primary empirical studies and institutional documents. The evidence supports a conditional answer. Supplier-facing collaboration and validated visibility plausibly protect supply, shortages causally raise medication errors, and substitution can be unsafe. No screened study connects sustainability-oriented practice, resilience capability and patient outcome within a single design. Procurement consolidation, meanwhile, shows gains at the buyer level alongside shortages at the facility level, which motivates a level-mismatch hypothesis. The article classifies practices, grades the evidence, advances seven falsifiable propositions and sets out a test design for Ghana. Its recommendations are that procurement criteria be segmented by clinical criticality, that supplier development come before exclusion, and that performance be reported at both buyer and facility levels.
No takes yet. Share an insight, caveat, or question.
BENJAMIN et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: